No Detail Found!

Non-Alcoholic Fatty Liver Disease and Prediabetes

Author(s)
Fariborz Mansour-Ghanaei Gastrointestinal and Liver Disease Research Center, Guilan University of Medical Sciences,Rasht,Iran
Alireza Jafarinejad Gastrointestinal and Liver Disease Research Center, Guilan University of Medical Sciences,Rasht,Iran
Zahra Atrkar Roshan Gastrointestinal and Liver Disease Research Center, Guilan University of Medical Sciences,Rasht,Iran
Hadi Khosravi Gastrointestinal and Liver Disease Research Center, Guilan University of Medical Sciences,Rasht,Iran
Amir Hassankhani Student Research Center, Guilan University of Medical Sciences,Rasht,Iran
Alireza Amir Maafi Student Research Center, Guilan University of Medical Sciences,Rasht,Iran
Abstract
BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is the most common liver disease in the world. The simultaneous occurrence of NAFLD and type 2 diabetes is common, however, few studies on the prevalence of NAFLD in prediabetic patients have been performed. Therefore, the aim of this study was to determine the prevalence of NAFLD by sonography in prediabetic patients and to compare the prevalence of NAFLD between prediabetic patients and normal population. METHODS: In this cross-sectional study, 191 consecutive prediabetic patients who were referred to the internal medicine clinic in the Razi Referral Hospital of Rasht, Iran, were compared with 191 healthy controls. Diagnosis of prediabetes was based on abnormal oral glucose tolerance test or fasting plasma glucose. Both groups underwent ultrasonography for the assessment of NAFLD and data was analyzed by Student's t test and Chi-square test. RESULTS: Patient population was between 20 and 70 years old and the mean age of participants was 41.04±12.66 years. Prediabetic group had 71(37.1%) males while healthy group had 84(43.9%) males. Of the 382 subjects, 142 (37.2%) had evidence of NAFLD on ultrasound examination of which 93(65.4%) were prediaibetics (P=0.001). CONCLUSION: We show that the prevalence of NAFLD in prediabetic patients is higher than healthy individual.
Publication Details
Page(s) 6-9
DOI DOI not available
Published Journal: Journal of Pioneering Medical Sciences, Volume: 6, Issue: 1, Year: 2016

Request the full text from PASTIC

Keywords
Ultrasonography, Non-Alcoholic Fatty Liver Disease, prediabetes
References
Garber AJ,Handelsman Y,Einhorn D,Bergman DA,Bloomgarden ZT,Fonseca V .2008 .Diagnosis and management of prediabetes in the continuum of hyperglycemia: when do the risks of diabetes begin? A consensus statement from the American College of Endocrinology and the American Association of Clinical Endocrinologists. Endocrine practice, 14(7) : 933-46.
Mavrogiannaki AN,Migdalis IN .2013 .Nonalcoholic Fatty liver disease, diabetes mellitus and cardiovascular disease: newer data. International Journal of Endocrinology, : 450639.
Paschos P,Paletas K. .2009 .Non alcoholic fatty liver disease and metabolic syndrome. Hippokratia, 13(1) : 9-19.
Shyangdan D,Clar C,Ghouri N,Henderson R,Gurung T,Preiss D .2011 .Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review. Health Technology Assessment, 15(38) : 1-110.
Ahmed M. .2015 .Non-alcoholic fatty liver disease in 2015. World journal of hepatology, 7(11) : 1450-9.
Kneeman JM,Misdraji J,Corey KE .2012 .Secondary causes of nonalcoholic fatty liver disease. Therapeutic Advances in Gastroenterology, 5(3) : 199-207.
Pereira K,Salsamendi J,Casillas J .2015 .The global nonalcoholic fatty liver disease epidemic: what a radiologist needs to know. Journal of Clinical Imaging Science, 5 : 32.
Day CP,James OF .1998 .Steatohepatitis: a tale of two "hits". ? Gastroenterology, 114(4) : 842-5.
Gusdon AM,Song KX,Qu S. Nonalcoholic .2014 .Fatty liver disease: pathogenesis and therapeutics from a mitochondria-centric perspective. Oxidative Medicine and Cellular Longevity, : 637027.
Nassir F,Ibdah JA .2014 .Role of mitochondria in nonalcoholic fatty liver disease. International Journal of Molecular Sciences, 15(5) : 8713-42.
van der Poorten D,Milner KL,Hui J,Hodge A,Trenell MI,Kench JG .2008 .Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology, 48(2) : 449-57.
Van Wagner LB,Rinella ME .2011 .The role of insulinsensitizing agents in the treatment of nonalcoholic steatohepatitis. Therapeutic Advances in Gastroenterology, 4(4) : 249-63.
Ortiz-Lopez C,Lomonaco R,Orsak B,Finch J,Chang Z,Kochunov VG .2012 .Prevalence of prediabetes and diabetes and metabolic profile of patients with nonalcoholic fatty liver disease (NAFLD). Diabetes Care, 35(4) : 873-8.
Singh SP,Singh A,Pati GK,Misra B,Misra D,Kar SK .2014 .A study of prevalence of diabetes and prediabetes in patients of non-alcoholic fatty liver disease and the impact of diabetes on liver histology in coastal eastern India. Journal of Diabetes Mellitus, 4(4) : 290-6.
Zelber-Sagi S,Lotan R,Shibolet O,Webb M,Buch A,Nitzan-Kaluski D .2013 .Non-alcoholic fatty liver disease independently predicts prediabetes during a 7- year prospective follow-up. Liver International, 33(9) : 1406-12.
Mottin CC,Moretto M,Padoin AV,Swarowsky AM,Toneto MG,Glock L .2004 .The role of ultrasound in the diagnosis of hepatic steatosis in morbidly obese patients. Obesity surgery, 14(5) : 635-7.
Barritt ASt,Dellon ES,Kozlowski T,Gerber DA,Hayashi PH .2011 .The influence of nonalcoholic fatty liver disease and its associated comorbidities on liver transplant outcomes. Journal of Clinical Gastroenterology, 45(4) : 372-8.
Bahcecioglu IH,Koruk M,Yilmaz O,Bolukbas C,Bolukbas F,Tuncer I .2006 .Demographic and clinicopathological characteristics of nonalcoholic fatty liver disease in the East-Southeastern Anatolia regions in Turkey. Medical Principles and Practice, 15(1) : 62-8.
Schwimmer JB MN,Deutsch R,Finegold MJ,Lavine JE .2005 .Influence of gender, race, and ethnicity on suspected fatty liver in obese adolescents. Pediatrics, 115 : 561-5.
Karpe F,Dickmann JR,Frayn KN .2011 .Fatty acids, obesity, and insulin resistance: time for a reevaluation. Diabetes, 60(10) : 2441-9.
Lankarani KB,Ghaffarpasand F,Mahmoodi M,Lotfi M,Zamiri N,Heydari ST .2013 .Non alcoholic fatty liver disease in southern Iran: a population based study. Hepatitis monthly, 13(5) : e9248.
0

Citations

0

Downloads

8

Views